FSLCX | VSMAX | FSLCX / VSMAX | |
Total Expense Ratio | 0.84 | 0.05 | 1,680% |
Annual Report Gross Expense Ratio | 0.84 | 0.05 | 1,680% |
Fund Existence | 27 years | 25 years | - |
Gain YTD | 1.028 | -2.861 | -36% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.03B | 140B | 1% |
Annual Yield % from dividends | 0.05 | 1.56 | 3% |
Returns for 1 year | 3.54 | 3.93 | 90% |
Returns for 3 years | 19.53 | 27.20 | 72% |
Returns for 5 years | 26.53 | 72.27 | 37% |
Returns for 10 years | -8.25 | 96.62 | -9% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
KORU | 46.89 | 1.60 | +3.53% |
Direxion Daily South Korea Bull 3X ETF | |||
EFAS | 17.40 | -0.07 | -0.40% |
Global X MSCI SuperDividend® EAFE ETF | |||
IMTB | 42.56 | -0.24 | -0.56% |
iShares Core 5-10 Year USD Bond ETF | |||
NIE | 22.97 | -0.21 | -0.91% |
Virtus Equity & Convertible Income Fund | |||
XBI | 79.33 | -2.07 | -2.54% |
SPDR® S&P Biotech ETF |